An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in
Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 …

We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …

We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA
from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids …

We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B. 1.429 to …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …

The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom,
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California …

An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in
Wuhan, China in December 2019 and the COVID-19 disease associated with infection has …

As of January of 2021, the highly transmissible B. 1.1. 7 variant of SARS-CoV-2, which was
first identified in the United Kingdom (UK), has gained a strong foothold across the world. …

Metagenomic next-generation sequencing (mNGS), the shotgun sequencing of RNA and
DNA from clinical samples, has proved useful for broad-spectrum pathogen detection and the …